National Health Investors, Inc. $NHI Position Boosted by Woodmont Investment Counsel LLC

Woodmont Investment Counsel LLC raised its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 33.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,705 shares of the real estate investment trust’s stock after acquiring an additional 19,444 shares during the quarter. Woodmont Investment Counsel LLC owned approximately 0.17% of National Health Investors worth $5,449,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its stake in National Health Investors by 15.8% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust’s stock valued at $268,000 after acquiring an additional 495 shares in the last quarter. Bank of New York Mellon Corp grew its stake in National Health Investors by 5.6% during the 1st quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust’s stock valued at $43,494,000 after acquiring an additional 31,451 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in National Health Investors by 11.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 3,611 shares of the real estate investment trust’s stock valued at $267,000 after acquiring an additional 357 shares in the last quarter. SG Americas Securities LLC purchased a new position in National Health Investors during the 1st quarter valued at about $808,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in National Health Investors by 3.3% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust’s stock valued at $35,372,000 after acquiring an additional 15,497 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Wells Fargo & Company lifted their target price on National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 27th. National Bankshares set a $90.00 price objective on National Health Investors in a report on Wednesday. KeyCorp upgraded National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 price objective on the stock in a report on Thursday, July 10th. Wedbush upgraded National Health Investors to a “strong-buy” rating in a report on Wednesday, July 2nd. Finally, Truist Financial increased their price objective on National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a report on Friday, August 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, National Health Investors presently has a consensus rating of “Buy” and an average target price of $84.83.

National Health Investors Stock Down 0.2%

Shares of National Health Investors stock opened at $78.47 on Monday. The stock has a market capitalization of $3.72 billion, a P/E ratio of 25.07, a PEG ratio of 3.37 and a beta of 0.77. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. The stock has a 50 day moving average price of $76.61 and a two-hundred day moving average price of $74.08. National Health Investors, Inc. has a 12-month low of $65.13 and a 12-month high of $82.32.

National Health Investors (NYSE:NHI) last announced its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to analysts’ expectations of $86.46 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The company’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.18 earnings per share. Equities analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This is an increase from National Health Investors’s previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a yield of 4.7%. National Health Investors’s dividend payout ratio (DPR) is currently 117.57%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.